MHRA selects RxSpec700z for drug anti-counterfeiting program
Download Press Release MHRA selects RxSpec700z for drug anti-counterfeiting program Cambridge, UK, 16th June 2011: The UK’s Medicines and Healthcare products Regulatory Authority (MHRA) has [...]
